Literature DB >> 28506086

Invasive cardiopulmonary exercise testing in the evaluation of unexplained dyspnea: Insights from a multidisciplinary dyspnea center.

Wei Huang1,2, Stephen Resch3, Rudolf Kf Oliveira2,4, Barbara A Cockrill2, David M Systrom2, Aaron B Waxman2.   

Abstract

Background Unexplained dyspnea is a common diagnosis that often results in repeated diagnostic testing and even delayed treatments while a determination of the cause is being investigated. Through a retrospective study, we evaluated the diagnostic efficacy of a multidisciplinary dyspnea evaluation center (MDEC) using invasive cardiopulmonary exercise test to diagnose potential causes of unexplained dyspnea. Methods We reviewed the medical records of all patients referred with unexplained dyspnea to the MDEC between March 2011 and October 2014. We assessed the diagnostic efficacy before and after presentation to the MDEC. Results During the study period a total of 864 patients were referred to the MDEC and, of those, 530 patients underwent further investigation with invasive cardiopulmonary exercise test and constituted the study sample. The median age was 57 (44-68) years, 67.2% were women, and median body mass index was 26.22 (22.78-31.01). A diagnosis was made in 530 patients including: exercise pulmonary arterial hypertension of 88 (16.6%), heart failure with preserved ejection fraction of 94 (17.7%), dysautonomia 112 (21.1%), oxidative myopathy of 130 (24.5%), primary hyperventilation of 43 (8.1%), and other 58 (10.9%). The time from initial presentation to referral was significantly longer than time to diagnosis after referral for non-standardized conventional methods versus diagnosis through MDEC using invasive cardiopulmonary exercise test (511 days (292-1095 days) vs. 27 days (13-53 days), p < 0.0001). In a subgroup analysis, we reviewed that patients referred from cardiovascular clinics were more likely to have a greater number of diagnostic tests performed and, conversely, patients referred from pulmonary clinics were more likely to have a greater number of treatments prescribed before referral to MDEC. Conclusions As a result of this retrospective study, we have evaluated that a multidisciplinary approach that includes invasive cardiopulmonary exercise test dramatically reduces the time to diagnosis compared with traditional treatment and testing methods.

Entities:  

Keywords:  Dyspnea; evaluation; exercise testing; exertional intolerance; invasive CPET

Mesh:

Year:  2017        PMID: 28506086     DOI: 10.1177/2047487317709605

Source DB:  PubMed          Journal:  Eur J Prev Cardiol        ISSN: 2047-4873            Impact factor:   7.804


  14 in total

1.  A Simple, Evidence-Based Approach to Help Guide Diagnosis of Heart Failure With Preserved Ejection Fraction.

Authors:  Yogesh N V Reddy; Rickey E Carter; Masaru Obokata; Margaret M Redfield; Barry A Borlaug
Journal:  Circulation       Date:  2018-08-28       Impact factor: 29.690

Review 2.  Performance and Interpretation of Invasive Hemodynamic Exercise Testing.

Authors:  C Charles Jain; Barry A Borlaug
Journal:  Chest       Date:  2020-05-28       Impact factor: 9.410

3.  [Heart or lung? : Diagnostics and management of unclear exertional dyspnea].

Authors:  H Wilkens; M Held
Journal:  Herz       Date:  2018-09       Impact factor: 1.443

4.  Correlation of Hemodynamic and Respiratory Parameters in Invasive Cardiopulmonary Exercise Testing (iCPET).

Authors:  Dirk Habedank; Anne Obst; Alexander Heine; Beate Stubbe; Ralf Ewert
Journal:  Life (Basel)       Date:  2022-04-28

Review 5.  Pathophysiology and clinical evaluation of the patient with unexplained persistent dyspnea.

Authors:  Andi Hudler; Fernando Holguin; Meghan Althoff; Anne Fuhlbrigge; Sunita Sharma
Journal:  Expert Rev Respir Med       Date:  2022-01-20       Impact factor: 4.300

6.  Insights From Invasive Cardiopulmonary Exercise Testing of Patients With Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

Authors:  Phillip Joseph; Carlo Arevalo; Rudolf K F Oliveira; Mariana Faria-Urbina; Donna Felsenstein; Anne Louise Oaklander; David M Systrom
Journal:  Chest       Date:  2021-02-10       Impact factor: 10.262

7.  Lung diffusion capacity in advanced heart failure: relation to central haemodynamics and outcome.

Authors:  Tania Deis; Louise Balling; Kasper Rossing; Emil Wolsk; Michael Perch; Finn Gustafsson
Journal:  ESC Heart Fail       Date:  2019-02-19

Review 8.  Dyspnea in Chronic Low Ventricular Preload States.

Authors:  Rubabin Tooba; Kenneth A Mayuga; Robert Wilson; Adriano R Tonelli
Journal:  Ann Am Thorac Soc       Date:  2021-04

9.  Investigation of dyspnea using cardiopulmonary exercise test among patients resorting to the respiratory tests.

Authors:  Seyedeh Zahra Fotook Kiaee; Besharat Rahimi
Journal:  Eur J Transl Myol       Date:  2018-07-10

10.  Comprehensive Diagnostic Evaluation of Cardiovascular Physiology in Patients With Pulmonary Vascular Disease: Insights From the PVDOMICS Program.

Authors:  W H Wilson Tang; Jennifer D Wilcox; Miriam S Jacob; Erika B Rosenzweig; Barry A Borlaug; Robert P Frantz; Paul M Hassoun; Anna R Hemnes; Nicholas S Hill; Evelyn M Horn; Harsimran S Singh; David M Systrom; Ryan J Tedford; Rebecca R Vanderpool; Aaron B Waxman; Lei Xiao; Jane A Leopold; Franz P Rischard
Journal:  Circ Heart Fail       Date:  2020-02-24       Impact factor: 8.790

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.